Free Trial

Aspire Biopharma (ASBP) Competitors

$0.39 0.00 (-1.18%)
As of 08:59 AM Eastern

ASBP vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ACABW, BFRIW, BTMDW, BCTXW, and CELUW

Should you be buying Aspire Biopharma stock or one of its competitors? The main competitors of Aspire Biopharma include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry.

Aspire Biopharma vs.

180 Life Sciences (NASDAQ:ATNFW) and Aspire Biopharma (NASDAQ:ASBP) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk, community ranking and earnings.

In the previous week, Aspire Biopharma had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for Aspire Biopharma and 0 mentions for 180 Life Sciences. Aspire Biopharma's average media sentiment score of 0.91 beat 180 Life Sciences' score of 0.00 indicating that Aspire Biopharma is being referred to more favorably in the news media.

Company Overall Sentiment
180 Life Sciences Neutral
Aspire Biopharma Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
Aspire BiopharmaN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
Aspire Biopharma N/A N/A N/A

180 Life Sciences and Aspire Biopharma both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
180 Life SciencesN/AN/A
Aspire BiopharmaOutperform Votes
No Votes
Underperform Votes
1
100.00%

19.2% of Aspire Biopharma shares are held by institutional investors. 48.0% of Aspire Biopharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Aspire Biopharma beats 180 Life Sciences on 4 of the 4 factors compared between the two stocks.

Get Aspire Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for ASBP and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ASBP vs. The Competition

MetricAspire BiopharmaPharmaceutical Preparations IndustryManufacturing SectorNASDAQ Exchange
Market Cap$19.32M$6.66B$2.02B$8.57B
Dividend YieldN/A2.62%2.63%4.19%
P/E RatioN/A8.5322.6619.93
Price / SalesN/A381.6864.45154.99
Price / CashN/A65.8551.7234.64
Price / BookN/A6.492.124.63
Net IncomeN/A$143.44M-$292.00M$247.95M
7 Day PerformanceN/A3.52%1.03%1.77%
1 Month PerformanceN/A4.00%8.08%8.69%
1 Year PerformanceN/A-0.24%14.82%10.70%

Aspire Biopharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ASBP
Aspire Biopharma
N/A$0.39
-1.2%
N/AN/A$19.09MN/A0.00N/A
ATNFW
180 Life Sciences
N/A$0.01
+8.1%
N/A+43.7%$0.00N/A0.007Positive News
Gap Up
High Trading Volume
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522,000.000.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.01
flat
N/A-92.6%$0.00N/A0.002Gap Up
AIMDW
Ainos
N/A$0.16
+6.9%
N/A+188.2%$0.00$106,207.000.0040Positive News
Gap Up
ALVOW
Alvotech
N/A$2.17
+5.9%
N/A-18.5%$0.00$585.60M0.004Positive News
Gap Up
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.01
-18.0%
N/AN/A$0.00N/A0.0015Gap Up
BFRIW
Biofrontera
N/A$0.09
+1.9%
N/AN/A$0.00$38.00M0.0070Gap Down
BTMDW
biote
N/A$0.02
-11.1%
N/AN/A$0.00$199.38M0.00N/A
BCTXW
BriaCell Therapeutics
N/A$0.09
+0.8%
N/A-80.2%$0.00N/A0.008Positive News
CELUW
Celularity
N/A$0.04
+0.3%
N/A+158.5%$0.00$54.22M0.00220Positive News
Gap Up

Related Companies and Tools


This page (NASDAQ:ASBP) was last updated on 6/5/2025 by MarketBeat.com Staff
From Our Partners